Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 6
Submit an article Journal homepage
861
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Monoclonal antibodies in neuroinflammatory diseases

Luisa KlotzDepartment of Neurology, Inflammatory Disorders of the Nervous System and Neurooncology, Clinic for Neurology, Albert-Schweitzer-Campus 1, Building A10, 48149 Münster, Germany
, MD &
Heinz WiendlDepartment of Neurology, Inflammatory Disorders of the Nervous System and Neurooncology, Clinic for Neurology, Albert-Schweitzer-Campus 1, building A10, 48149 Münster, Germany+49 251 83 46811; +49 251 83 46812; [email protected]
, MD
Pages 831-846 | Published online: 22 Mar 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Qing Xie, Benjamin Moore & Richard L. Beardsley. (2016) Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies. mAbs 8:2, pages 371-378.
Read now

Articles from other publishers (11)

Wenli Zhu, Yaling Zhang, Zhen Wang, Ying Fu & Yaping Yan. (2020) Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside. Neuroscience Bulletin 36:10, pages 1213-1224.
Crossref
João Peres, Rita Martins, José Delgado Alves & Ana Valverde. (2017) Rituximab in generalized myasthenia gravis: Clinical, quality of life and cost–utility analysis. Porto Biomedical Journal 2:3, pages 81-85.
Crossref
A. Nandoskar, J. Raffel, A. S. Scalfari, T. Friede & R. S. Nicholas. (2017) Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis. Drugs 77:8, pages 885-910.
Crossref
Stefan Bittner, Tobias Ruck, Heinz Wiendl, Oliver M. Grauer & Sven G. Meuth. (2016) Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management. Therapeutic Advances in Neurological Disorders 10:1, pages 51-66.
Crossref
Catharina C. GrossDiana AhmetspahicTobias RuckAndreas Schulte-MecklenbeckKathrin SchwarteSilke JörgensStefanie ScheuSusanne WindhagenBettina GraefeNico MelzerLuisa KlotzVolker AroltHeinz WiendlSven G. MeuthJudith Alferink. (2016) Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation 3:6.
Crossref
Wei Wang, Kun Fang, Miao-Chen Li, Di Chang, Khawar Ali Shahzad, Tao Xu, Lei Zhang, Ning Gu & Chuan-Lai Shen. (2016) A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo . Oncotarget 7:11, pages 12176-12190.
Crossref
Stefan Bittner & Heinz Wiendl. (2015) Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications. Neurotherapeutics 13:1, pages 4-19.
Crossref
Katsuhiro Sasaki, Angela Bean, Shivanee Shah, Elizabeth Schutten, Priya G. Huseby, Bjorn Peters, Zu T. Shen, Vijay Vanguri, Denny Liggitt & Eric S. Huseby. (2014) Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells. The Journal of Immunology 192:7, pages 3029-3042.
Crossref
Zoe Hunter, Derrick P. McCarthy, Woon Teck Yap, Christopher T. Harp, Daniel R. Getts, Lonnie D. Shea & Stephen D. Miller. (2014) A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease. ACS Nano 8:3, pages 2148-2160.
Crossref
Giovanni D'Arena & Luca Laurenti. (2014) Alemtuzumab and Treatment of Chronic Lymphocytic Leukemia and Its Immune-Related Disorders: One Player on Two Tables. Acta Haematologica 132:2, pages 237-239.
Crossref
Maria Podbielska, Naren Banik, Ewa Kurowska & Edward Hogan. (2013) Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination. Brain Sciences 3:4, pages 1282-1324.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.